Clinical Trial

Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere'

Study acronym: SPARKLE-2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Advanced cancer patients often experience significant physical and emotional symptoms, which can lead to frequent hospital visits and reduced quality of life. Although palliative care can help manage these symptoms and improve well-being, it is often introduced too late. A proactive symptom monitoring model, SPARKLE-2 aims to identify patients who need palliative care earlier by regularly checking their symptoms using a simple questionnaire. Patients with concerned symptoms will receive timely support from the palliative care team, with the goal of improving their quality of life, reducing unnecessary hospital admissions, and helping more patients receive care in the community rather than in hospital. In the earlier SPARKLE-1 study, it showed the improvement of patients' physical wellbeing. SPARKLE-2 seeks to test the effectiveness among advanced cancer patients with unplanned hospital visits while simultaneously collecting data on real-world implementation.
Trial Details
NCT Number NCT07745816
Lead Sponsor National Cancer Centre, Singapore
Conditions Neoplasms, Palliative Care
Enrollment 300 participants
Start Date 2026-08-01
Primary Completion 2029-03-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04